Results 251 to 260 of about 1,579,650 (291)
Reply: Refining the Prognostic Interpretation of Myocardial PD-L1 Expression in ICI-Associated Myocarditis. [PDF]
Imaoka T +4 more
europepmc +1 more source
DNA damage response as a driver of PD-L1 expression in cellular senescence: implications for immune evasion and immunosenescence. [PDF]
Wang Y, Qin L.
europepmc +1 more source
CBFB-MYH11 directly activates TGFβ and PD-L1 to drive immune evasion in acute myeloid leukemia. [PDF]
Fang H +18 more
europepmc +1 more source
ANKRD49 promotes immune evasion in lung adenocarcinoma by activating the MEF2A/PD‑L1 axis. [PDF]
Sun TQ +8 more
europepmc +1 more source
CCT2 Promotes Immune Escape in Colorectal Cancer by Regulating the JAK1-STAT3-PD-L1 Axis. [PDF]
Gu L, Li S, Tang Y, Ji L.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nature Cell Biology, 2020
PD-L1 has been extensively described as the membrane-bound ligand of PD-1. A recent study discovered a previously unknown role for PD-L1, which is able to bind DNA and thus govern different pathways linked to either evasion of immune surveillance or tumour microenvironment inflammation.
Alison Jaccard, Ping-Chih Ho
openaire +4 more sources
PD-L1 has been extensively described as the membrane-bound ligand of PD-1. A recent study discovered a previously unknown role for PD-L1, which is able to bind DNA and thus govern different pathways linked to either evasion of immune surveillance or tumour microenvironment inflammation.
Alison Jaccard, Ping-Chih Ho
openaire +4 more sources
PD1 and PD-L1 Inhibitors for the Treatment of Kidney Cancer: The Role of PD-L1 Assay
Current Drug Targets, 2020Background: Immune checkpoint inhibitors targeting the programmed death receptor ligand 1 (PD-L1)/programmed death receptor 1 (PD-1) pathway represent a drastic change in the treatment landscape of RCC resulting in a dynamic and evolving scenario.
Cimadamore A. +7 more
openaire +4 more sources

